Published in Arterioscler Thromb Vasc Biol on February 01, 1996
Optimal lipid modification: the rationale for combination therapy. Vasc Health Risk Manag (2005) 0.82
Inhibition of ileal apical but not basolateral bile acid transport reduces atherosclerosis in apoE⁻/⁻ mice. Atherosclerosis (2013) 0.81
Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action. Core Evid (2012) 0.76
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) (1988) 7.02
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Recording by the police of violent offences; an Accident and Emergency Department perspective. Med Sci Law (1989) 4.75
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation (2001) 4.32
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med (2000) 3.90
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation (2001) 3.57
Prevention of cardiovascular disease in general practice: a proposed model. Br Med J (Clin Res Ed) (1986) 3.56
Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med (1991) 3.31
Lower patients' cholesterol now. BMJ (1995) 3.23
The present role of coronary artery surgery. Practitioner (1982) 3.08
Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia (2006) 2.88
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Blood-lead levels, behaviour, and intelligence. A population study. Lancet (1974) 2.75
A statement for extensive primary cytoreductive surgery in advanced ovarian cancer. BJOG (2008) 2.71
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Preventing injuries from bar glasses. BMJ (1994) 2.51
Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet (1982) 2.51
Nucleotide sequence of IS26, a new prokaryotic mobile genetic element. Nucleic Acids Res (1983) 2.48
Incidence of high blood lead levels in Chicago children. Pediatrics (1969) 2.46
The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. BMJ (1997) 2.44
Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology (2008) 2.33
Induction of labour using prostaglandin E2 pessaries. Br Med J (1979) 2.23
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol (1999) 2.18
Fully automatic determination of soil bacterium numbers, cell volumes, and frequencies of dividing cells by confocal laser scanning microscopy and image analysis. Appl Environ Microbiol (1995) 2.15
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Extra-amniotic prostaglandin E2 and the unfavourable cervix. Lancet (1976) 2.13
A method in search of a theory: peer education and health promotion. Health Educ Res (1999) 2.10
Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg (1990) 2.07
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. Eur Heart J (2002) 1.98
Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial. Heart (2001) 1.93
Quantification of breast tissue index from MR data using fuzzy clustering. Conf Proc IEEE Eng Med Biol Soc (2004) 1.93
Normal catecholamine production in a patient with a paroxysmally secreting phaeochromocytoma. Ann Clin Biochem (1991) 1.91
Receptor-mediated low density lipoprotein catabolism in man. J Lipid Res (1979) 1.88
Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism. N Engl J Med (1980) 1.87
Leg-vein thrombosis following myocardial infarction. Lancet (1970) 1.85
Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol Invest (1998) 1.79
Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation (2001) 1.78
Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol (1996) 1.78
Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg (2000) 1.75
The civil hospitals in the Crimea (1855-1856). Proc R Soc Med (1966) 1.72
Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res (1998) 1.70
A general practitioner electrocardiogram service. Scott Med J (1967) 1.69
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest (1978) 1.69
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) (1984) 1.69
Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr (1998) 1.68
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol (1997) 1.68
Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg (1993) 1.66
Protein synthesis in rat liver: influence of amino acids in diet on microsomes and polysomes. Science (1965) 1.63
Whither rural practice? Med J Aust (1995) 1.61
Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol (1997) 1.59
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis (2000) 1.58
3 and 12 lead electrocardiogram interpretation by computer. A comparison on 1093 patients. Br Heart J (1971) 1.56
Development and use of a population based injury surveillance system: the all Wales Injury Surveillance System (AWISS). Inj Prev (2002) 1.56
A new porcine bioprosthesis: in vitro and in vivo evaluation. Life Support Syst (1985) 1.55
Three-dimensional x-ray analysis of normal movement in the lumbar spine. Spine (Phila Pa 1976) (1984) 1.53
Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology (2009) 1.52
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation (2000) 1.51
Surgery in the small hospital. Lancet (1971) 1.50
Blood pressure in a Scottish island community. Br Med J (1969) 1.50
Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis (2000) 1.50
Supporting victims of violent crime. BMJ (1988) 1.50
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia (1997) 1.49
International economic analysis of primary prevention of cardiovascular disease with pravastatin in WOSCOPS. West of Scotland Coronary Prevention Study. Eur Heart J (1999) 1.46
Age, gender, and race/ethnic differences in total body and subregional bone density. Osteoporos Int (2008) 1.46
In vitro calcification of bioprosthetic heart valves: report of a novel method and review of the biochemical factors involved. J Heart Valve Dis (1992) 1.45
Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia. Bone Marrow Transplant (1999) 1.45
Unintended effects and their detection in genetically modified crops. Food Chem Toxicol (2004) 1.44
A pilot scheme for improving the accuracy of serum cholesterol measurement in Scotland and Northern Ireland. Ann Clin Biochem (1993) 1.44
Blood pressure and catecholamine responses to 'stress' in normotensive and hypertensive subjects. Cardiovasc Res (1971) 1.43
The influence of alcohol consumed with a meal on endothelial function in healthy individuals. J Hum Nutr Diet (2010) 1.43
Relation between extent of coronary artery disease and blood viscosity. Br Med J (1980) 1.42
The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review. Health Technol Assess (2011) 1.42
Plasma albumin and haemodilution: the problem of interpretation in sequential studies. Ann Clin Biochem (1989) 1.42
Histidinaemia. Study of relation between clinical and biological findings in 7 subjects. Arch Dis Child (1972) 1.41
Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med (2006) 1.40
Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis (1994) 1.40
The Charing Cross Hospital experience with temozolomide in patients with gliomas. Eur J Cancer (1996) 1.40
Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab (1997) 1.39
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
Transition from school to community living. Am J Occup Ther (1994) 1.39
The isolation, characterisation and quantification of the equine plasma lipoproteins. Equine Vet J (1991) 1.39